Cerebrovascular changes in chronic hypertension: Protective effects of enalapril in rats

Stroke

Volumn 28, Issue 5, 1997, Pages 1028-1034

  Nag, Sukriti ^a   Kilty, Daniel W ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b NONE

Author keywords

blood brain barrier; enalapril; extracellular matrix; hypertension; immunohistochemistry; rats

Indexed keywords

COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FIBRONECTIN; LAMININ;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MICROCIRCULATION; CELL MEMBRANE PERMEABILITY; CHRONIC DISEASE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PIA ARTERY; PRIORITY JOURNAL; RAT;

EID: 0030994477     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.5.1028     Document Type: Article

References (31)

1. Chester EM, Agamanolis DP, Banker BQ, Victor M. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology. 1978;28:928-939.
2. Rosenberg EF. The brain in malignant hypertension: a clinicopathological study. Arch Intern Med. 1940;65:545-586.
3. Scheinker IM. Hypertensive disease of the brain. Arch Pathol. 1943; 36:259-296.
4. Baumbach GL, Walmsley JG, Hart MN. Composition and mechanics of cerebral arterioles in hypertensive rats. Am J Pathol. 1988;133:464-471.
5. Nag S, Robertson DM, Dinsdale HB. Morphological changes in spontaneously hypertensive rats. Acta Neuropathol (Berl). 1980;52: 27-34.
6. Fredriksson K, Nordborg C, Kalimo H, Olsson Y, Johansson BB. Cerebral microangiopathy in stroke-prone spontaneously hypertensive rats: an immunohistochemical and ultrastructural study. Acta Neuropathol (Berl). 1988;75:241-252.
7. Hart MN, Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980;2:419-423.
8. Nag S. Immunohistochemical localization of extracellular matrix proteins in cerebral vessels in chronic hypertension. J Neuropathol Exp Neurol. 1996;55:381-388.
9. Nag S. Cerebral changes in chronic hypertension: combined permeability and immunohistochemical studies. Acta Neuropathol (Berl). 1984;62:178-184.
10. Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T. Vascular changes underlying cerebral lesions in stroke-prone spontaneously hypertensive rats: a serial section study. Acta Neuropathol (Berl). 1981;54:183-188.
11. Hazama F, Amano S, Haebara H, Yamori Y, Okamoto K. Pathology and pathogenesis of cerebrovascular lesions in spontaneously hypertensive rats. In: Cervós-Navarro J, Betz E, Matakas F, Wüllenweber R, eds. Cerebral Vessel Wall. New York, NY: Raven Press Publishers; 1976:245-252.
12. Nag S, Robertson DM, Dinsdale HB. Quantitative estimate of pinocytosis in experimental acute hypertension. Acta Neuropathol (Berl). 1979;46:107-116.
13. Clozel J-P, Kuhn H, Hefti F. Effects of cilazapril on the cerebral circulation in spontaneously hypertensive rats. Hypertension. 1989; 14:645-651.
14. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive treatment on mechanics of cerebral arterioles in rats. Hypertension. 1991;17:308-316.
15. Lee RMKW, Richardson M, McKenzie R. Vascular changes associated with deoxycorticosterone-NaCl-induced hypertension. Blood Vessels. 1989;26:137-156.
16. 2+-ATPase) in intracerebral arterioles in acute hypertension. Acta Neuropathol (Berl). 1988;75:547-553.
17. Schiffrin EL. Reactivity of small blood vessels in hypertension: relation with structural changes. Hypertension. 1992;19(suppl II):II-1-II-9.
18. Limas C, Westrum B, Limas CJ. Effect of antihypertensive therapy on the vascular changes of spontaneously hypertensive rats. Am J Pathol. 1983;111:380-393.
19. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension. 1991;17:141-150.
20. Korner PI, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995;25:610-619.
21. Tikkanen I, Omvik P, Jensen AE. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens. 1995;13:1343-1351.
22. Todd PA, Goa KL. Enalapril: a reappraisal of its pharmacology and therapeutic use in hypertension. Drugs. 1992;43:346-381.
23. Roggendorf W, Opitz H, Schuppan D. Altered expression of collagen type IV in brain vessels of patients with chronic hypertension: a comparison with the distribution of collagen IV and procollagen III. Acta Neuropathol (Berl). 1988;77:55-60.
24. Takasaki I, Chobanian AV, Sarzani R, Brecher P. Effect of hypertension on fibronectin expression in rat aorta. J Biol Chem. 1990; 265:21935-21939.
25. Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG. Intraglomerular pressure and mesangial stretching stimulate extra-cellular matrix formation in the rat. J Clin Invest. 1992;90: 1932-1943.
26. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
27. Himeno H, Crawford DC, Hosoi M, Chobanian AV, Brecher P. Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension. 1994;23:823-826.
28. Giordano MT, Germano I, Giaccone G, Mauro A, Migheli A, Schiffer D. The distribution of laminin in human brain tumors: an immunohistochemical study. Acta Neuropathol (Berl). 1985;67: 51-57.
29. Taruscio D, Malchiodi Albedi F, Bagnato R, Pauluzzi S, Francisci D, Cavaliere A, Donelli G. Increased reactivity of laminin in the basement membranes of capillary walls in AIDS brain cortex. Acta Neuropathol (Berl). 1991;81:552-556.
30. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Yomino Y, Koide H. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol. 1995;5:1492-1497.
31. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest. 1986;77:1925-1930.